Developer docs
API playgroundTry for free, no card

Search company profiles

ScienceMachine

Full company profile

uuid0000roa

Namestring
ScienceMachine
Legal namestring
ScienceMachine
Company typeenum
Private
Founded yearint
2024
Descriptiontext

ScienceMachine is a London-based AI platform company that develops autonomous AI agents to automate end-to-end biomedical research and development workflows. Its flagship product, 'Sam,' is an autonomous bioinformatics agent that ingests raw laboratory data—including mass spectrometry and flow cytometry output—performs analysis and visualization, interprets results against referenced scientific literature, and produces reports and slides, with the ability to adapt to each lab's specific guidelines and preferences. The company serves biotech and pharmaceutical researchers as well as broader life sciences organizations, with named users including Flow Health Sciences, Inoviv, and Mitocholine.

ScienceMachine monetizes via a tiered SaaS subscription: a free tier for evaluation, a Pro plan for individual regular users (monthly or annual), a fixed-price Team plan with 10 seats and unlimited queries, and a custom Enterprise plan featuring tailored integrations, dedicated expert support, increased compute, enterprise-grade encryption, and multi-year contracts. Distribution combines a product-led growth motion through self-serve signup at app.sciencemachine.ai with a sales-led enterprise motion for larger deployments.

The company was founded in 2024 (per firmographic data), operates with 1-10 employees, and is headquartered in London, United Kingdom. In July 2025 it closed a $3.5 million pre-seed round led by Revent and Nucleus Capital (with Juniper and Opal Ventures also participating). Strategic commercial validation is in progress via a partnership with Artelo Biosciences on its FABP5 inhibitor program, and the company has co-developed the BixBench benchmark with FutureHouse and published BioML-bench to establish evaluation standards for AI agents in computational biology and biomedical machine learning. A claimed outcome of 90% reduction in biopharma experimentation is cited from a deployed customer case.

Short descriptiontext

ScienceMachine is a London-based AI platform company offering 'Sam,' an autonomous bioinformatics agent that automates end-to-end biomedical R&D workflows—from raw mass spectrometry and flow cytometry data through analysis, visualization, and report generation—for biotech and pharmaceutical researchers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical AI platform, biotech data analysis, autonomous research agents, scientific data automation, bioinformatics AI software
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers513210
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Prepackaged Software7372
  • Laboratory Analytical Instruments3826
Product category
AI Bioinformatics Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Subscription (Tiered Plans)
TypeSubscription Recurring
Description

ScienceMachine generates revenue through tiered SaaS subscription plans: Free (limited usage), Pro (premium features for individuals), Team (fixed-price with shared access for research teams), and Enterprise (custom pricing for large organizations). Annual billing options available for Pro and Team plans, with custom limits and support for Enterprise deployments.

sciencemachine.ai
2Freemium Model
TypeFreemium
Description

A free tier is offered to attract researchers with limited usage, serving as a lead generation and onboarding mechanism that converts users to paid Pro and Team plans as their needs scale.

sciencemachine.ai
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details4 tiers
1Free plan for exploring ScienceMachine with usage limits
ModelFreemiumBilling cadencePay-as-you-go
Notes

$0 free forever, no credit card required. Includes standard data processing, generic capabilities, basic security and privacy, no expert support, no custom integrations, limited file size.

sciencemachine.ai
2Pro plan for regular users with higher query limits and premium features
ModelSubscriptionBilling cadenceMonthly
Notes

Premium features, faster support, larger file size limits. Built for regular individual use. Monthly or annual billing.

sciencemachine.ai
3Team plan for research teams with shared access and central billing
ModelSubscriptionBilling cadenceMonthly
Notes

Unlimited queries, 10 seats included, invite and remove teammates, read-only workbook sharing by URL. Fixed-price plan.

sciencemachine.ai
4Enterprise plan for organizations needing custom deployment and integrations
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom limits and support, tailored to organization, increased compute resources, tailored to research, custom integrations, dedicated expert support, enterprise-grade security, never used for training, enterprise encryption, never shared with others.

sciencemachine.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

ScienceMachine provides an autonomous AI bioinformatics agent platform (Sam) that automates end-to-end biomedical R&D workflows — from raw laboratory data ingestion through mass spectrometry and flow cytometry processing, analysis, and visualization, to automated report and slide generation. The platform is sold as a tiered SaaS subscription (Free, Pro, Team, Enterprise) and is purpose-built for biotech and pharmaceutical researchers who need to replace manual, bespoke data analysis with 24/7 agent-driven automation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 90% reduction in biopharma experimentation
Product overview1 text field

ScienceMachine offers an AI platform for biomedical R&D comprising the core ScienceMachine Platform and its autonomous AI bioinformatics agent named Sam. The platform automates end-to-end workflows—from raw biomedical data processing (mass spectrometry, flow cytometry) through analysis and visualization to final report generation—powered by AI agents that adapt to specific research guidelines. Pricing tiers include Free, Pro, Team, and Enterprise plans with varying capabilities.

Product and service1 record
1ScienceMachine Platform (with Sam AI agent)
CategoryAI Bioinformatics Software
Description

An AI platform for biomedical research that automates end-to-end workflows from raw laboratory data to final reports. Powered by the autonomous AI bioinformatics agent Sam, it processes mass spectrometry and flow cytometry data, performs analysis and visualization, generates reports and slides, and interprets results against referenced scientific literature. Sold to biotech and pharmaceutical researchers and life sciences enterprises via Free, Pro, Team, and Enterprise SaaS subscriptions.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

ScienceMachine entered a strategic partnership with Artelo Biosciences to accelerate development of its fatty acid-binding protein 5 (FABP5) inhibitor platform using cutting-edge AI agent technology. Since 2025, ScienceMachine has analyzed Artelo's large internal FABP datasets, identified potential proteins indicative of FABP5 target engagement in ART26.12-treated healthy volunteers, and revealed biological networks associated with disease severity and FABP signaling. The partnership aims to expand Artelo's pipeline potential, enhance R&D precision, and shorten the path to value creation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ScienceMachine collaborated with FutureHouse to develop and publish BixBench, a comprehensive benchmark for LLM-based agents in computational biology. This partnership establishes evaluation standards for AI agents in biomedical research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Scientific informatics platform for R&D including data management, analysis, and visualization. Competes in the same biomedical data workflow space with established enterprise pharma customers.

TypeBroad incumbent
Description

Cloud platform for biotech R&D with LIMS, ELN, and workflow tools. Broad incumbent serving similar biotech/pharma researchers with a comprehensive data management suite rather than autonomous AI agents.

TypeBroad incumbent
Description

Synthetic biology platform with extensive automated lab infrastructure. Competes for AI-driven biology R&D budgets and operates a similar automated lab paradigm that ScienceMachine's agent targets as customers.

TypeEmerging player
Description

AI-driven biotech using live-cell imaging and automation for drug discovery. Competes in the AI-for-biomedical-research category and represents a sophisticated potential customer or competitor for automated lab data analysis.

TypeBroad incumbent
Description

Techbio company using AI and high-throughput biology for drug discovery. Represents both a competitor for AI-driven biology R&D dollars and a potential large customer for biomedical data analysis tooling.

TypeEmerging player
Description

AI platform for protein engineering and biologics design. Competes in the AI-for-biotech R&D space, focused on a different vertical (protein design) but addressing the same biotech AI tooling budget.

TypeBroad incumbent
Description

Scientific data cloud platform that ingests and harmonizes lab instrument data including mass spec and flow cytometry. Addresses similar data integration and analysis needs in life sciences R&D.

TypeEmerging player
Description

AI platform for biomedical research using federated learning. Targets similar pharma/biotech R&D customers and represents an adjacent AI-for-biology competitor with overlap in ML-driven scientific workflows.

TypeEmerging player
Description

AI-driven drug discovery company combining ML with biology. Competes for AI-enabled biomedical R&D budgets and represents the type of biotech customer ScienceMachine could serve.

TypeDirect peer
Description

AI research agent platform for scientific discovery. Direct peer that collaborated with ScienceMachine on the BixBench benchmark, building similar autonomous agents for biology research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ScienceMachine

AI Bioinformatics Softwaresciencemachine.ai

ScienceMachine is a London-based AI platform company offering 'Sam,' an autonomous bioinformatics agent that automates end-to-end biomedical R&D workflows—from raw mass spectrometry and flow cytometry data through analysis, visualization, and report generation—for biotech and pharmaceutical researchers.

What ScienceMachine does

ScienceMachine is a London-based AI platform company that develops autonomous AI agents to automate end-to-end biomedical research and development workflows. Its flagship product, 'Sam,' is an autonomous bioinformatics agent that ingests raw laboratory data—including mass spectrometry and flow cytometry output—performs analysis and visualization, interprets results against referenced scientific literature, and produces reports and slides, with the ability to adapt to each lab's specific guidelines and preferences. The company serves biotech and pharmaceutical researchers as well as broader life sciences organizations, with named users including Flow Health Sciences, Inoviv, and Mitocholine.

ScienceMachine monetizes via a tiered SaaS subscription: a free tier for evaluation, a Pro plan for individual regular users (monthly or annual), a fixed-price Team plan with 10 seats and unlimited queries, and a custom Enterprise plan featuring tailored integrations, dedicated expert support, increased compute, enterprise-grade encryption, and multi-year contracts. Distribution combines a product-led growth motion through self-serve signup at app.sciencemachine.ai with a sales-led enterprise motion for larger deployments.

The company was founded in 2024 (per firmographic data), operates with 1-10 employees, and is headquartered in London, United Kingdom. In July 2025 it closed a $3.5 million pre-seed round led by Revent and Nucleus Capital (with Juniper and Opal Ventures also participating). Strategic commercial validation is in progress via a partnership with Artelo Biosciences on its FABP5 inhibitor program, and the company has co-developed the BixBench benchmark with FutureHouse and published BioML-bench to establish evaluation standards for AI agents in computational biology and biomedical machine learning. A claimed outcome of 90% reduction in biopharma experimentation is cited from a deployed customer case.

ScienceMachine firmographics

Firmographics
Name
ScienceMachine
Legal name
ScienceMachine
Website
https://sciencemachine.ai
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
ScienceMachine is a London-based AI platform company offering 'Sam,' an autonomous bioinformatics agent that automates end-to-end biomedical R&D workflows—from raw mass spectrometry and flow cytometry data through analysis, visualization, and report generation—for biotech and pharmaceutical researchers.
Ownership category
akta.pro rank

ScienceMachine industry classification

Industry
Product category
AI Bioinformatics Software
NAICS
Software Publishers (513210), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Prepackaged Software (7372), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Biomedical AI platform
  • Biotech data analysis
  • Autonomous research agents
  • Scientific data automation
  • Bioinformatics AI software

Where ScienceMachine is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ScienceMachine business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Subscription (Tiered Plans): ScienceMachine generates revenue through tiered SaaS subscription plans: Free (limited usage), Pro (premium features for individuals), Team (fixed-price with shared access for research teams), and Enterprise (custom pricing for large organizations). Annual billing options available for Pro and Team plans, with custom limits and support for Enterprise deployments.
  2. Freemium Model: A free tier is offered to attract researchers with limited usage, serving as a lead generation and onboarding mechanism that converts users to paid Pro and Team plans as their needs scale.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree plan for exploring ScienceMachine with usage limits
SubscriptionMonthlyPro plan for regular users with higher query limits and premium features
SubscriptionMonthlyTeam plan for research teams with shared access and central billing
SubscriptionMulti-year contractEnterprise plan for organizations needing custom deployment and integrations

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

ScienceMachine product offering

Product offering

Core offering

ScienceMachine provides an autonomous AI bioinformatics agent platform (Sam) that automates end-to-end biomedical R&D workflows — from raw laboratory data ingestion through mass spectrometry and flow cytometry processing, analysis, and visualization, to automated report and slide generation. The platform is sold as a tiered SaaS subscription (Free, Pro, Team, Enterprise) and is purpose-built for biotech and pharmaceutical researchers who need to replace manual, bespoke data analysis with 24/7 agent-driven automation.

Product overview

ScienceMachine offers an AI platform for biomedical R&D comprising the core ScienceMachine Platform and its autonomous AI bioinformatics agent named Sam. The platform automates end-to-end workflows—from raw biomedical data processing (mass spectrometry, flow cytometry) through analysis and visualization to final report generation—powered by AI agents that adapt to specific research guidelines. Pricing tiers include Free, Pro, Team, and Enterprise plans with varying capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • ScienceMachine Platform (with Sam AI agent) An AI platform for biomedical research that automates end-to-end workflows from raw laboratory data to final reports. Powered by the autonomous AI bioinformatics agent Sam, it processes mass spectrometry and flow cytometry data, performs analysis and visualization, generates reports and slides, and interprets results against referenced scientific literature. Sold to biotech and pharmaceutical researchers and life sciences enterprises via Free, Pro, Team, and Enterprise SaaS subscriptions.

Quantifiable outcome

  • 90% reduction in biopharma experimentation

Companies that use ScienceMachine

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

ScienceMachine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature9 records

ScienceMachine partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Artelo BiosciencescoreStrategic or Co-development Partner · 1 January 2025ScienceMachine entered a strategic partnership with Artelo Biosciences to accelerate development of its fatty acid-binding protein 5 (FABP5) inhibitor platform using cutting-edge AI agent technology. Since 2025, ScienceMachine has analyzed Artelo's large internal FABP datasets, identified potential proteins indicative of FABP5 target engagement in ART26.12-treated healthy volunteers, and revealed biological networks associated with disease severity and FABP signaling. The partnership aims to expand Artelo's pipeline potential, enhance R&D precision, and shorten the path to value creation.
  • FutureHousecoreStrategic or Co-development PartnerScienceMachine collaborated with FutureHouse to develop and publish BixBench, a comprehensive benchmark for LLM-based agents in computational biology. This partnership establishes evaluation standards for AI agents in biomedical research.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

ScienceMachine competitors and assessment

Company assessment

Broad incumbents

  • Dotmatics: Scientific informatics platform for R&D including data management, analysis, and visualization. Competes in the same biomedical data workflow space with established enterprise pharma customers.
  • Benchling: Cloud platform for biotech R&D with LIMS, ELN, and workflow tools. Broad incumbent serving similar biotech/pharma researchers with a comprehensive data management suite rather than autonomous AI agents.
  • Ginkgo Bioworks: Synthetic biology platform with extensive automated lab infrastructure. Competes for AI-driven biology R&D budgets and operates a similar automated lab paradigm that ScienceMachine's agent targets as customers.
  • Recursion: Techbio company using AI and high-throughput biology for drug discovery. Represents both a competitor for AI-driven biology R&D dollars and a potential large customer for biomedical data analysis tooling.
  • TetraScience: Scientific data cloud platform that ingests and harmonizes lab instrument data including mass spec and flow cytometry. Addresses similar data integration and analysis needs in life sciences R&D.

Emerging players

  • Eikon Therapeutics: AI-driven biotech using live-cell imaging and automation for drug discovery. Competes in the AI-for-biomedical-research category and represents a sophisticated potential customer or competitor for automated lab data analysis.
  • Cradle: AI platform for protein engineering and biologics design. Competes in the AI-for-biotech R&D space, focused on a different vertical (protein design) but addressing the same biotech AI tooling budget.
  • Owkin: AI platform for biomedical research using federated learning. Targets similar pharma/biotech R&D customers and represents an adjacent AI-for-biology competitor with overlap in ML-driven scientific workflows.
  • Insitro: AI-driven drug discovery company combining ML with biology. Competes for AI-enabled biomedical R&D budgets and represents the type of biotech customer ScienceMachine could serve.

Direct peers

  • FutureHouse: AI research agent platform for scientific discovery. Direct peer that collaborated with ScienceMachine on the BixBench benchmark, building similar autonomous agents for biology research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

ScienceMachine social profiles

Digital presence

ScienceMachine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ScienceMachine leadership team

Management profile

Number of profiles

ScienceMachine funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ScienceMachine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ScienceMachine

What does ScienceMachine do?

ScienceMachine provides an autonomous AI bioinformatics agent platform (Sam) that automates end-to-end biomedical R&D workflows — from raw laboratory data ingestion through mass spectrometry and flow cytometry processing, analysis, and visualization, to automated report and slide generation. The platform is sold as a tiered SaaS subscription (Free, Pro, Team, Enterprise) and is purpose-built for biotech and pharmaceutical researchers who need to replace manual, bespoke data analysis with 24/7 agent-driven automation.

When was ScienceMachine founded?

ScienceMachine was founded in 2024. It employs 11 to 50 people.

Where is ScienceMachine based?

ScienceMachine is headquartered in San Francisco, United States, in the North America region.

How does ScienceMachine make money?

Two revenue lines are on record. SaaS Subscription (Tiered Plans) is the primary driver. The others are freemium Model.

Who are ScienceMachine's main competitors?

Broad incumbents on record are Dotmatics, Benchling, Ginkgo Bioworks, Recursion and TetraScience. Emerging players are Eikon Therapeutics, Cradle, Owkin and Insitro. FutureHouse is listed as a direct peer.

Does ScienceMachine have an API?

No public API is recorded for ScienceMachine.

What industry is ScienceMachine in?

ScienceMachine's product category is AI Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAG, Lab Automation, Instrument Control & Workflow Orchestration Software. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireArtelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor DevelopmentArtelo Biosciences announced a strategic partnership with ScienceMachine, an AI platform company for biomedical R&D, to accelerate the development of its fatty acid-binding protein 5 (FABP5) inhibitor platform using cutting-edge AI agent technology. Since the collaboration began in 2025, ScienceMachine has analyzed Artelo's large internal FABP datasets, identified potential proteins indicative of FABP5 target engagement in ART26.12-treated healthy volunteers, and revealed biological networks associated with disease severity and FABP signaling. The partnership aims to expand Artelo's pipeline potential, enhance R&D precision, and shorten the path to value creation for its drug development strategy.Tech.euScienceMachine raises $3.5M for leading autonomous AI in biotech researchScienceMachine, a London-based AI startup, raised $3.5 million in pre-seed funding led by Revent and Nucleus Capital. Its autonomous AI agent, Sam, automates biotech data analysis, with early customers reporting results a third of the time. The company plans to expand from biotech startups into larger companies.VestbeeUK-based biotech startup ScienceMachine raises $3.5M pre-seed roundScienceMachine, a UK-based biotech startup, raised a $3.5 million pre-seed round led by Revent and Nucleus Capital. The funds will be used to develop its AI product, hire staff, and expand its customer base from biotech startups to larger companies.